Chromosome studies in "preleukemia". III. Myelofibrosis

Area of Science:

• Hematology
• Cytogenetics
• Oncology

Background:

• Myelofibrosis (MF) and undifferentiated myeloproliferative disorder (MPD) are hematologic neoplasms characterized by bone marrow fibrosis.
• The prognostic significance of cytogenetic abnormalities in MF/MPD remains an area of active investigation.
• Previous studies suggest a potential link between chromosomal aberrations and disease progression in some preleukemic states.

Purpose of the Study:

• To investigate the frequency and patterns of cytogenetic abnormalities in patients diagnosed with myelofibrosis or undifferentiated MPD.
• To determine if specific chromosomal alterations correlate with clinical or hematologic findings in this patient cohort.
• To assess the predictive value of observed cytogenetic abnormalities for the progression to acute leukemia.

Main Methods:

• Cytogenetic analysis was performed on peripheral blood samples from 18 patients with MF or undifferentiated MPD.
• Patients were monitored for disease progression, including the development of leukemia, for at least 1 year or until death.
• Hematologic parameters were correlated with cytogenetic findings.

Main Results:

• Chromosome abnormalities were detected in the blood of 8 out of 18 patients (44%).
• Trisomy 8 was observed in two patients with acute myelofibrosis, but no other consistent cytogenetic pattern emerged.
• None of the 16 followed patients progressed to overt leukemia during the observation period.

Conclusions:

• Cytogenetic abnormalities are relatively common in myelofibrosis and undifferentiated MPD.
• Unlike some other preleukemic conditions, aberrant clones in MF/MPD do not appear to indicate an imminent risk of leukemia.
• The presence of chromosome abnormalities in MF/MPD may not be a reliable indicator of leukemic transformation.